• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?

作者信息

Funck-Brentano Christian, Salem Joe-Elie

机构信息

AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France.

AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France.

出版信息

Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31174-0.

DOI:10.1016/S0140-6736(20)31174-0
PMID:32450109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7255131/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd12/7255131/eb0f784d8382/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd12/7255131/eb0f784d8382/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd12/7255131/eb0f784d8382/fx1_lrg.jpg

相似文献

1
Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?氯喹或羟氯喹用于治疗新型冠状病毒肺炎：为何它们可能具有危险性？
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31174-0.
2
Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.羟氯喹和氯喹在 COVID-19 患者中的应用：随机临床试验的荟萃分析。
Pathog Glob Health. 2021 May;115(3):139-150. doi: 10.1080/20477724.2021.1884807. Epub 2021 Feb 11.
3
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.为何您的患者认为羟氯喹和氯喹对新冠病毒病有90%的疗效是极其危险的。
J Clin Pharmacol. 2020 Aug;60(8):949-953. doi: 10.1002/jcph.1687. Epub 2020 Jul 1.
4
Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma.羟氯喹/氯喹作为发展中国家初级保健水平治疗或预防新冠病毒的选择：一个首要非伤害困境。
J Neurol Sci. 2020 Aug 15;415:116972. doi: 10.1016/j.jns.2020.116972. Epub 2020 Jun 3.
5
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.氯喹和羟氯喹在治疗性使用或过量使用后的毒性。
Clin Toxicol (Phila). 2021 Jan;59(1):12-23. doi: 10.1080/15563650.2020.1817479. Epub 2020 Sep 22.
6
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
7
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
8
Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil.羟氯喹或氯喹联合或不联合阿奇霉素治疗 COVID-19 患者的真实世界数据：巴西的回顾性分析。
Arq Bras Cardiol. 2023 Sep;120(9):e20220935. doi: 10.36660/abc.20220935.
9
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
10
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.氯喹和羟氯喹耳毒性对 COVID-19 治疗的临床意义：小型综述。
Front Public Health. 2020 May 29;8:252. doi: 10.3389/fpubh.2020.00252. eCollection 2020.

引用本文的文献

1
Targeting natural products against SARS-CoV-2.针对 SARS-CoV-2 的天然产物靶向治疗。
Environ Sci Pollut Res Int. 2022 Jun;29(28):42404-42432. doi: 10.1007/s11356-022-19770-2. Epub 2022 Apr 1.
2
Protocol of investigation into reporting quality of RCT abstracts on COVID-19 pursuant to CONSORT (CoCo study)-a review.COVID-19 随机对照试验摘要报告质量调查方案：CONSORT（CoCo 研究）-综述。
Trials. 2021 Dec 24;22(1):952. doi: 10.1186/s13063-021-05937-8.
3
The protective role of vitamin C in the management of COVID-19: A Review.

本文引用的文献

1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
2
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
3
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.
维生素C在新型冠状病毒肺炎治疗中的保护作用：综述
J Egypt Public Health Assoc. 2021 Dec 11;96(1):33. doi: 10.1186/s42506-021-00095-w.
4
Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?羟氯喹和氯喹在预防和治疗新型冠状病毒肺炎中的应用：已知情况有哪些？
J Pharm Bioallied Sci. 2021 Jan-Mar;13(1):4-10. doi: 10.4103/jpbs.JPBS_404_20. Epub 2020 Oct 6.
5
Clinical Research Redirection and Optimization During a Pandemic.大流行期间的临床研究转向和优化。
Anesthesiol Clin. 2021 Jun;39(2):379-388. doi: 10.1016/j.anclin.2021.03.004.
6
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.治疗方案对 SARS-CoV-2 冠状病毒抗体反应的影响。
Front Immunol. 2021 Apr 15;12:580147. doi: 10.3389/fimmu.2021.580147. eCollection 2021.
7
Progress in the risk assessment of hydroxychloroquine in frail elderly people.老年体弱人群中羟氯喹风险评估的进展
Aging Med (Milton). 2020 Dec 25;4(1):53-57. doi: 10.1002/agm2.12140. eCollection 2021 Mar.
8
Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review.严重急性呼吸综合征冠状病毒2感染的治疗方法：药理学观点及文献综述
Iran J Pharm Res. 2020 Summer;19(3):258-281. doi: 10.22037/ijpr.2020.113821.14506.
9
COVID-19 and the generation of novel scientific knowledge: Research questions and study designs.新型冠状病毒肺炎与新科学知识的产生：研究问题与研究设计。
J Eval Clin Pract. 2021 Jun;27(3):694-707. doi: 10.1111/jep.13550. Epub 2021 Feb 15.
10
From quarantine room: Physician perspective.来自隔离病房：医生视角。
J Family Med Prim Care. 2020 Oct 30;9(10):5092-5102. doi: 10.4103/jfmpc.jfmpc_896_20. eCollection 2020 Oct.
评估多离子通道阻滞：I 期随机研究设计的结果：CiPA I 期心电图生物标志物验证研究。
Clin Pharmacol Ther. 2019 Apr;105(4):943-953. doi: 10.1002/cpt.1303. Epub 2019 Jan 18.
4
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.联合使用延长 QT 间期药物的致心律失常附加效应。
Cardiovasc Toxicol. 2018 Feb;18(1):84-90. doi: 10.1007/s12012-017-9416-0.
5
Azithromycin Causes a Novel Proarrhythmic Syndrome.阿奇霉素会引发一种新型的心律失常综合征。
Circ Arrhythm Electrophysiol. 2017 Apr;10(4). doi: 10.1161/CIRCEP.115.003560.
6
Antimicrobials and QT prolongation.抗菌药物与QT间期延长
J Antimicrob Chemother. 2017 May 1;72(5):1272-1274. doi: 10.1093/jac/dkw591.
7
Early treatment with intravenous lipid emulsion in a potentially lethal hydroxychloroquine intoxication.在潜在致命的羟氯喹中毒中早期使用静脉注射脂质乳剂治疗。
Neth J Med. 2016 Jun;74(5):210-4.
8
An update on risk factors for drug-induced arrhythmias.药物性心律失常危险因素的最新进展。
Expert Rev Clin Pharmacol. 2016;9(1):117-27. doi: 10.1586/17512433.2016.1100073. Epub 2015 Oct 13.
9
Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.德国有症状的药物诱导长 QT 综合征和尖端扭转型室性心动过速的流行病学。
Europace. 2014 Jan;16(1):101-8. doi: 10.1093/europace/eut214. Epub 2013 Jul 5.
10
Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.女性比男性更容易出现药物诱导的QT间期延长吗？一项口服消旋索他洛尔的1期研究中的浓度-QTc建模。
Br J Clin Pharmacol. 2014 Mar;77(3):522-31. doi: 10.1111/bcp.12201.